VEGFA and neoplasm: Altogether, preclinical studies support the hypothesis that LKB1 triggers complex changes in the tumor microenvironment involving different targets that impact directly or indirectly on VEGF signaling and possibly other additional angiogenic pathways [42] (Figure 1).